Caligan Partners LP's Form 4 filing
Standard Biotools Inc. (LAB) · filed Apr 8, 2022
- Accession no.
- 0000902664-22-002486
- Filed
- Apr 8, 2022, 5:19 PM ET
- Trade date
- Apr 6-8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.92M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Caligan Partners LPCIK 0001727492 | 10% Owner |
| Johnson David EdwardCIK 0001785557 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2022 | Common Stock, $0.001 par value per share ("Common Stock") | PPurchaseAcquired | +109,573 | $3.60 | +$394,462.8 | 8,489,838 | Indirect | |
| Apr 7, 2022 | Common Stock | PPurchaseAcquired | +200,000 | $3.88 | +$776,000 | 8,689,838 | Indirect | |
| Apr 8, 2022 | Common Stock | PPurchaseAcquired | +200,000 | $3.76 | +$752,000 | 8,889,838 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.